Biotech

All Articles

Oncternal stock sinks 60% in the middle of discharges, trial firings

.Cancer cells provider Oncternal Therapies is actually folding all its clinical tests and laying off...

Roche is carrying out hopes that its own injectable obesity prospect might inevitably illustrate 25% weight reduction in late-stage test

.Roche is actually holding out hopes that its injectable obesity prospect could at some point displa...

Novo Nordisk hails 'remarkable' weight loss result for dual-acting oral medication in very early test

.Novo Nordisk has elevated the top on a period 1 test of its own dental amylin and GLP-1 receptor co...

AbbVie sues BeiGene over blood cancer cells medication secret method

.Simply a couple of quick weeks after winning an FDA Fast Track tag for its own investigational BTK ...

Lilly supplies one-two blow along with 2nd tranche of good records on once a week insulin candidate

.Quickly after a positive data reduce for Eli Lilly's efsitora alfa, the Indianapolis-based provider...

BridgeBio cuts gene therapy spending plan as clinical records dissatisfy

.BridgeBio Pharma is actually slashing its own genetics therapy budget plan as well as pulling back ...

GSK gives up HSV vaccination really hopes after period 2 fail, yielding nationality to Moderna, BioNTech

.GSK's attempt to build the initial injection for genital herpes simplex infection (HSV) has actuall...

GSK's long-acting asthma medicine halved assaults in stage 3

.GSK's long-acting asthma treatment has been shown to cut in half the variety of strikes in a pair o...

AstraZeneca, Daiichi unbox Dato-DXd's overall survival stop working

.AstraZeneca as well as Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has neglected ...

Roivant introduces brand new 'vant' to evolve Bayer hypertension med

.Matt Gline is back with a brand new 'vant' firm, after the Roivant Sciences CEO paid Bayer $14 mill...